Aspira Pathlab & Diagnostics Limited
ASPIRA.BO
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.18B
Close$
$32.69
72.8% downside
Current Fair Value
72.8% downsideOvervalued by 72.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.18 Billion |
|---|---|
| Enterprise Value | $1.18 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.05 |
| Beta | 0.39 |
| Outstanding Shares | 10,293,000 |
Return
| Return on Equity | -3.70% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -257.5 |
|---|---|
| PEG | 236.36 |
| Price to Sales | 4.82 |
| Price to Book Ratio | 10.95 |
| Enterprise Value to Revenue | 4.57 |
| Enterprise Value to EBIT | -365.45 |
| Enterprise Value to Net Income | -262 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Aspira Pathlab & Diagnostics Limited
168 employees
CEO: Pankaj Jashwant Shah Aspira Pathlab & Diagnostics Ltd. specializes in managing diagnostic centers and laboratories. The company performs an extensive range of pathological analyses, encompassing biochemistry, hematology, histopathology, microbiology, immunoc...